VivoSim Labs, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
VivoSim Labs, Inc. (VIVS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $38.00 thousand for the 12-month period ending 2016-03-31, per its 10-K filed 2018-05-31.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-05-31
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2014-03-31 was $40.00K.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2013-12-31 was -$315.00K.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2013-09-30 was $0.00.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2013-06-30 was $767.00K.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $38.00K, a 87.97% decline from fiscal 2015.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $316.00K, a 35.77% decline from fiscal 2014.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2014 was $492.00K.
- VivoSim Labs, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $890.00K, a 19.89% decline from fiscal 2011.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|
| 2016-03-31 | $38.00K 10-K · filed 2018-05-31 | ||||
| 2015-03-31 | $316.00K 10-K · filed 2017-06-07 | ||||
| 2014-03-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | -$275.00K derived: sum of 2 quarters · filed 2016-06-09 | -$275.00K derived: sum of 3 quarters · filed 2016-06-09 | $492.00K 10-K · filed 2016-06-09 | |
| 2013-12-31 | -$315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | -$315.00K derived: sum of 2 quarters · filed 2014-02-06 | $452.00K 10-Q · filed 2014-02-06 | ||
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $767.00K 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | $767.00K 10-Q · filed 2013-08-09 | ||||
| 2012-12-31 | $890.00K 10-K · filed 2015-06-09 | ||||
| 2011-12-31 | $1.11M 10-K · filed 2014-06-10 | $1.11M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |